drugset / Trial / NCT00829712

Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions

NCT00829712

Phase 1 Completed 24 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this randomized, single-dose, two-way evaluation is to compare the bioequivalence of a test dexmethylphenidate hydrochloride formulation to an equivalent oral dose of the commercially available dexmethylphenidate hydrochloride in a test population of 24 adult subjects under fasted conditions.

Timeline

Start
2004-06
Primary completion
2004-06
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator dexmethylphenidate Unknown 10 mg Oral

Indications

No indication recorded.